Skip to main content
S&P 5007,659.44-1.09%DOW52,002.41-0.34%NASDAQ26,140.03-2.14%BTC$81,442.00-0.92%ETH$2,417.14-0.81%GOLD$4,186.70+0.40%OIL$99.04+2.63%
Smart Investors Daily
SID Premium
IS

NASDAQ · ISPC

iSpecimen Inc.

Healthcare · Medical - Diagnostics & Research

$0.92

Down-$0.11 (-10.97%)

Updated Oct 18, 2026, 1:51 PM

SID Score

4.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.64M
P/E ratio
-0.24
Dividend yield
0.00%
52-week range
$0.10 – $7.29
Volume
47.53K
Avg. volume
1.91M

Price performance · ISPC

ISPC price history

1M range · 0 trading sessions · Daily adjusted prices

ISPC does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest ISPC news

The latest Smart Investors Daily articles mentioning ISPC.

Stock researchCompany · Overview

ISPC research

Overview

Company profile and research snapshot.

Company profile

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
ISPC recent ratings
DateFirmRatingTarget
Sep 23, 2022EF HuttonBuy—
Jan 4, 2022Craig-HallumBuy—
Nov 22, 2021EF HuttonBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 29, 2026

iSpecimen Supports Hospital Validation of New Chemistry Analyzer

Company coordinates collection of more than 1,700 human specimens to support new laboratory testing capabilitiesWoburn, Massachusetts--(Newsfile Corp. - September 29, 2026) - iSpecimen, a provider of human biospecimens, is supporting a hospital laboratory in the validation of a new chemistry analyzer for clinical use. For the project, iSpecimen identified a healthcare system already using the same analyzer and is coordinating the collection of more than 1,700 serum, plasma, cerebrospinal fluid..

Benzinga · Sep 8, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By